Cancer affects millions of people each year – not only those who are diagnosed,
but also families, friends, and communities. How can we help give people a better chance at beating
cancer? Early detection. It can make all the difference. The sooner cancer is found, the quicker
curative treatment can begin.
Find out how those who live with and work with cancer are rewriting the narrative
in a brand-new digital series presented by Union for International Cancer Control and produced for
them by BBC StoryWorks Commercial Productions.
The series explores innovative solutions for cancer prevention, diagnosis,
treatment and care, and spotlights DeepHealth’s role in transforming lung cancer screening.
Please accept
statistics and marketing
cookies to watch this video. Change consent
Please accept
statistics and marketing
cookies to watch this video. Change consent
Empowering breakthroughs in care by unlocking the
value
of imaging
DeepHealth is a global leader in AI-powered health informatics for
real-world
settings. Our solutions address both clinical and operational challenges that arise in complex,
high-volume care settings, streamlining the entire workflow to ease the burden on providers and
enable a more seamless experience – for care teams and patients.
“AI is a complete game changer of population screening programs.”
Sham Sokka
Chief Operating and Technology Officer, DeepHealth
“The data that we now have from the Targeted Lung Health Checks is that 75% of the cancers we’re picking up are early stage, that’s stages one and two.”
Dr. Sophie Tisi
Respiratory Physician
“I’m working in symbiosis with the AI, and I have to genuinely say, hand on my heart, that AI has made me a better radiologist.”
Prof. Sam Hare
Consultant Chest Radiologist & CEO Health and Lung Health
Screening at scale
Discover how our AI-powered solutions are transforming healthcare by providing
advanced imaging and data analytics to improve patient outcomes and operational efficiency.
RadNet, Inc. (NASDAQ: RDNT), of which DeepHealth is a wholly-owned subsidiary, reported on May 8, 2024, first quarter financial results with record first quarter revenue, Adjusted EBITDA(1) and adjusted earnings(3) and revises upwards 2024 financial guidance ranges.
Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection rates, risk stratification tools, and viewing and reporting workflow acceleration.
SOMERVILLE, Mass., Feb. 26, 2026 — DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced that TechLive™, its FDA-cleared remote imaging and radiology management solution, has achieved CE marking, enabling European commercialization of the industry’s first solution that extends oversight across MR, CT, PET/CT and ultrasound. Designed to expand imaging capacity and access to complex procedures, TechLive enables European healthcare providers to more effectively manage workforce needs and expand access to advanced imaging. Additionally, TechLive is now listed in AWS Marketplace to streamline access and accelerate deployment timelines worldwide.
References:
1) New lung cancer screening roll out to
detect cancer sooner – GOV.UK
2) Unpublished data from a study of 14 radiology practices (200 sites) in the United States. Data on file.
3) Cipollari et al., Radiologia Medica, 2022.
4) Hempel HL, Engbersen MP, Wakkie J, van Kelckhoven BJ, de Monyé W. Higher agreement between readers with deep
learning CAD software for reporting pulmonary nodules on CT. Eur J Radiol Open. 2022 Aug 2;9:100435. doi:
10.1016/j.ejro.2022.100435. PMID: 35942077; PMCID: PMC9356194.